Standard Family Office LLC Alnylam Pharmaceuticals, Inc. Transaction History

Standard Family Office LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $3,492 - $4,909	29 New	29 $4,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $5,087 - $6,956	-40 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $6,382 - $8,371	40 New	40 $7,000
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $2,206 - $2,700	-13 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $1,672 - $2,299	13 New	13 $2,000
Q1 2021 May 12, 2021	SELL	$126.83 - $175.69 $1,395 - $1,932	-11 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $1,352 - $1,617	11 New	11 $1,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.